AN2 Therapeutics Inc (ANTX)
2.32
+0.04
(+1.75%)
USD |
NASDAQ |
Apr 26, 16:00
2.32
0.00 (0.00%)
After-Hours: 20:00
AN2 Therapeutics Stock Buybacks (Quarterly): 0.321M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.321M |
| September 30, 2023 | -65.80M |
| June 30, 2023 | -19.05M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.01M |
| Date | Value |
|---|---|
| June 30, 2022 | -7.178M |
| March 31, 2022 | -63.20M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-65.80M
Minimum
Sep 2023
0.321M
Maximum
Dec 2023
-12.91M
Average
--
Median
Mar 2021
Stock Buybacks (Quarterly) Benchmarks
| Gilead Sciences Inc | 124.00M |
| QuidelOrtho Corp | 3.70M |
| CymaBay Therapeutics Inc (DELISTED) | 0.444M |
| Insmed Inc | -114.46M |
| Revance Therapeutics Inc | 0.00 |